This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Gilead Sciences Inc. rose 3.7% to $122.56 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 6,846.61 and the Dow Jones Industrial Average rising 1.2% to 47,927.96.
The stock's rise snapped a two-day losing streak.
Gilead Sciences Inc. closed 1.6% short of its 52-week high of $124.61, which the company achieved on October 21st.
The stock demonstrated a mixed performance when compared to some of its peers, as Johnson & Johnson rose 2.9% to $193.83, Pfizer Inc. rose 4.6% to $25.51, and Abbott Laboratories rose 0.88% to $127.00.
Trading volume totaled 6.1 million, compared to the 50-day average of 7.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 11, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.